Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
August 26, 2017
Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: Two-year experience
Brandi Vollmer, Kavita V Nair, Stefan H Sillau, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Public Health
Brandi Vollmer, Christian G Habeck, Vrinda Kalia, et al.
Journal of the Neurological Sciences
|
May 27, 2018
The impact of very short transition times on switching from Natalizumab to Fingolimod on imaging and clinical effectiveness outcomes in multiple sclerosis
Brandi Vollmer, Justin M Honce, Stefan Sillau, et al.
Current Epidemiology Reports
|
December 18, 2025
Consideration of Cardiovascular Morbidities in the Relationship between Ambient Air Pollution Exposure and Individual-Level Adverse COVID-19 Outcomes: A Systematic Review
Sneha Kannoth, Kavitha Ganesan, Brandi Vollmer, et al.
Journal of the Neurological Sciences
|
October 24, 2019
Comparative discontinuation, effectiveness, and switching practices of dimethyl fumarate and fingolimod at 36-month follow-up
Brandi Vollmer, Daniel Ontaneda, Haleigh Harris, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
October 21, 2020
Use of Smokeless Tobacco Before Conception and Its Relationship With Maternal and Fetal Outcomes of Pregnancy in Thatta, Pakistan: Findings From Women First Study
Sumera Aziz Ali, Umber Khan, Farina Abrejo, et al.
Neurology. Clinical Practice
|
August 25, 2018
Discontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centers
Brandi Vollmer, Daniel Ontaneda, Anasua Bandyopadhyay, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
August 26, 2017
Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: Two-year experience
Brandi Vollmer, Kavita V Nair, Stefan H Sillau, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Public Health
Brandi Vollmer, Christian G Habeck, Vrinda Kalia, et al.
Journal of the Neurological Sciences
|
May 27, 2018
The impact of very short transition times on switching from Natalizumab to Fingolimod on imaging and clinical effectiveness outcomes in multiple sclerosis
Brandi Vollmer, Justin M Honce, Stefan Sillau, et al.
Current Epidemiology Reports
|
December 18, 2025
Consideration of Cardiovascular Morbidities in the Relationship between Ambient Air Pollution Exposure and Individual-Level Adverse COVID-19 Outcomes: A Systematic Review
Sneha Kannoth, Kavitha Ganesan, Brandi Vollmer, et al.
Journal of the Neurological Sciences
|
October 24, 2019
Comparative discontinuation, effectiveness, and switching practices of dimethyl fumarate and fingolimod at 36-month follow-up
Brandi Vollmer, Daniel Ontaneda, Haleigh Harris, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
October 21, 2020
Use of Smokeless Tobacco Before Conception and Its Relationship With Maternal and Fetal Outcomes of Pregnancy in Thatta, Pakistan: Findings From Women First Study
Sumera Aziz Ali, Umber Khan, Farina Abrejo, et al.
Neurology. Clinical Practice
|
August 25, 2018
Discontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centers
Brandi Vollmer, Daniel Ontaneda, Anasua Bandyopadhyay, et al.
Page
of 1